Technavio recombinant proteins market report has been prepared by focusing on both qualitative & quantitative aspects which cover- market trends, market drivers, Five forces analysis, challenges, key factors, Market size and forecast, Market segmentation, Geographical insights, and Competitive Landscape. View Free Sample Report of Recombinant Proteins Market in MINUTES.
Recombinant Proteins Market Vendors
- Abcam plc
- Airway Therapeutics Inc.
- Amgen Inc.
- Aviva Systems Biology Corp.
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- BPS Bioscience Inc.
- Elabscience Biotechnology Inc.
- Enzo Biochem Inc.
- GenScript Biotech Corp.
- GigaGen Inc.
- Merck KGaA
- Novartis AG
The recombinant proteins market will be affected by an increase in collaborations and strategic alliances by vendors. Apart from this, other market trends include Increased expenditure on R&D, Growing opportunities from emerging economies. Buy Sample Report.
Recombinant Proteins Market Split
- By Application
- Biotechnology research
- Drug discovery and development
- Biopharmaceutical production
- Others
- By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The market analysis is done on the basis of regional distribution helping us to utilize & make performance estimations for the international market over the period from 2021-2026. The recombinant proteins market research report shed light on the foremost regions: North America, Europe, Asia, and the Rest of the World (ROW). Download Free Sample Report.
Imperative Insights on the following aspects:
- What was the size of the global recombinant proteins industry by value?
- What will be the size of the global recombinant proteins industry in 2026?
- What factors are affecting the strength of competition in the global recombinant proteins industry?
- How has the industry performed over the last five years?
- What are the main segments that make up the global recombinant proteins market?
The recombinant proteins market research report presents critical information and factual data about the recombinant proteins industry, with an overall statistical study of this market based on market drivers, market limitations, and its future prospects. The widespread trends and opportunities are also taken into consideration in the recombinant proteins market study.
Related Reports:
Myoglobin Market by Type and Geography - Forecast and Analysis 2022-2026: The myoglobin market share is expected to increase by USD 99.2 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.1%.
Human Organoids Market by End-user and Geography - Forecast and Analysis 2022-2026: The human organoids market share is expected to increase to USD 1.18 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 16.9%.
Recombinant Proteins Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.98% |
Market growth 2022-2026 |
$ 633.23 million |
Market structure |
Fragmented |
YoY growth (%) |
9.5 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 36% |
Key consumer countries |
US, Canada, Germany, Italy, China, and Japan |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Bio Techne Corp., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., GigaGen Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi, Sino Biological Inc., and Thermo Fisher Scientific Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse for Technavio "Health Care" Research Reports
Table of Content:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Application
- 5.1 Market segments
- Exhibit 24: Chart on Application - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
- 5.2 Comparison by Application
- Exhibit 26: Chart on Comparison by Application
- Exhibit 27: Data Table on Comparison by Application
- 5.3 Biotechnology research - Market size and forecast 2021-2026
- Exhibit 28: Chart on Biotechnology research - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Biotechnology research - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Biotechnology research - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Biotechnology research - Year-over-year growth 2021-2026 (%)
- 5.4 Drug discovery and development - Market size and forecast 2021-2026
- Exhibit 32: Chart on Drug discovery and development - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Drug discovery and development - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Drug discovery and development - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Drug discovery and development - Year-over-year growth 2021-2026 (%)
- 5.5 Biopharmaceutical production - Market size and forecast 2021-2026
- Exhibit 36: Chart on Biopharmaceutical production - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Biopharmaceutical production - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Biopharmaceutical production - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Biopharmaceutical production - Year-over-year growth 2021-2026 (%)
- 5.6 Others - Market size and forecast 2021-2026
- Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
- Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
- 5.7 Market opportunity by Application
- Exhibit 44: Market opportunity by Application ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 46: Chart on Market share by geography 2021-2026 (%)
- Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 48: Chart on Geographic comparison
- Exhibit 49: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.9 Germany - Market size and forecast 2021-2026
- Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.10 Italy - Market size and forecast 2021-2026
- Exhibit 78: Chart on Italy - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Italy - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Italy - Year-over-year growth 2021-2026 (%)
- 7.11 Japan - Market size and forecast 2021-2026
- Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.12 Canada - Market size and forecast 2021-2026
- Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.13 Market opportunity by geography
- Exhibit 90: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 91: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 93: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 94: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 95: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 96: Matrix on vendor position and classification
- 10.3 Abcam plc
- Exhibit 97: Abcam plc - Overview
- Exhibit 98: Abcam plc - Product / Service
- Exhibit 99: Abcam plc - Key news
- Exhibit 100: Abcam plc - Key offerings
- 10.4 Amgen Inc.
- Exhibit 101: Amgen Inc. - Overview
- Exhibit 102: Amgen Inc. - Product / Service
- Exhibit 103: Amgen Inc. - Key offerings
- 10.5 Bio Rad Laboratories Inc.
- Exhibit 104: Bio Rad Laboratories Inc. - Overview
- Exhibit 105: Bio Rad Laboratories Inc. - Business segments
- Exhibit 106: Bio Rad Laboratories Inc. - Key news
- Exhibit 107: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 108: Bio Rad Laboratories Inc. - Segment focus
- 10.6 Enzo Biochem Inc.
- Exhibit 109: Enzo Biochem Inc. - Overview
- Exhibit 110: Enzo Biochem Inc. - Business segments
- Exhibit 111: Enzo Biochem Inc. - Key offerings
- Exhibit 112: Enzo Biochem Inc. - Segment focus
- 10.7 Merck KGaA
- Exhibit 113: Merck KGaA - Overview
- Exhibit 114: Merck KGaA - Business segments
- Exhibit 115: Merck KGaA - Key news
- Exhibit 116: Merck KGaA - Key offerings
- Exhibit 117: Merck KGaA - Segment focus
- 10.8 Novartis AG
- Exhibit 118: Novartis AG - Overview
- Exhibit 119: Novartis AG - Business segments
- Exhibit 120: Novartis AG - Key offerings
- Exhibit 121: Novartis AG - Segment focus
- 10.9 Novo Nordisk AS
- Exhibit 122: Novo Nordisk AS - Overview
- Exhibit 123: Novo Nordisk AS - Business segments
- Exhibit 124: Novo Nordisk AS - Key offerings
- Exhibit 125: Novo Nordisk AS - Segment focus
- 10.10 Sanofi
- Exhibit 126: Sanofi - Overview
- Exhibit 127: Sanofi - Business segments
- Exhibit 128: Sanofi - Key news
- Exhibit 129: Sanofi - Key offerings
- Exhibit 130: Sanofi - Segment focus
- 10.11 Sino Biological Inc.
- Exhibit 131: Sino Biological Inc. - Overview
- Exhibit 132: Sino Biological Inc. - Product / Service
- Exhibit 133: Sino Biological Inc. - Key offerings
- 10.12 Thermo Fisher Scientific Inc.
- Exhibit 134: Thermo Fisher Scientific Inc. - Overview
- Exhibit 135: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 136: Thermo Fisher Scientific Inc. - Key news
- Exhibit 137: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 138: Thermo Fisher Scientific Inc. - Segment focus
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 139: Inclusions checklist
- Exhibit 140: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 141: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 142: Research methodology
- Exhibit 143: Validation techniques employed for market sizing
- Exhibit 144: Information sources
- 11.5 List of abbreviations
- Exhibit 145: List of abbreviations
- investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact Us:
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article